These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9121810)

  • 21. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of epidural butorphanol versus epidural morphine in postoperative pain relief.
    Parikh GP; Veena SR; Vora K; Parikh B; Joshi A
    Middle East J Anaesthesiol; 2014 Feb; 22(4):371-6. PubMed ID: 25007690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study.
    Rosenthal M; Moore P; Groves E; Iwan T; Schlosser LG; Dziewanowska Z; Negro-Vilar A
    J Opioid Manag; 2007; 3(3):145-54. PubMed ID: 18027540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
    Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
    Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.
    Finn JW; Walsh TD; MacDonald N; Bruera E; Krebs LU; Shepard KV
    J Clin Oncol; 1993 May; 11(5):967-72. PubMed ID: 8487059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic efficacy of morphine applied topically to painful ulcers.
    Zeppetella G; Paul J; Ribeiro MD
    J Pain Symptom Manage; 2003 Jun; 25(6):555-8. PubMed ID: 12782436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine or oxycodone in cancer pain?
    Heiskanen TE; Ruismäki PM; Seppälä TA; Kalso EA
    Acta Oncol; 2000; 39(8):941-7. PubMed ID: 11207001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
    Southworth S; Peters J; Rock A; Pavliv L
    Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].
    Bono AV; Cuffari S
    Drugs; 1997; 53 Suppl 2():40-9. PubMed ID: 9190324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
    Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
    Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study.
    Sloan P; Slatkin N; Ahdieh H
    Support Care Cancer; 2005 Jan; 13(1):57-65. PubMed ID: 15538638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone for cancer pain.
    Nicholson AB
    Cochrane Database Syst Rev; 2004; (2):CD003971. PubMed ID: 15106230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on cancer patients' health-related quality of life after the start of morphine therapy.
    Klepstad P; Borchgrevink PC; Kaasa S
    J Pain Symptom Manage; 2000 Jul; 20(1):19-26. PubMed ID: 10946165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.
    Peat S; Sweet P; Miah Y; Barklamb M; Larsen U
    Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation.
    Viscusi ER; Martin G; Hartrick CT; Singla N; Manvelian G;
    Anesthesiology; 2005 May; 102(5):1014-22. PubMed ID: 15851890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cebranopadol: A Novel, First-in-Class, Strong Analgesic: Results from a Randomized Phase IIa Clinical Trial in Postoperative Acute Pain.
    Scholz A; Bothmer J; Kok M; Hoschen K; Daniels S
    Pain Physician; 2018 May; 21(3):E193-E206. PubMed ID: 29871387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
    Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
    J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.